Cytokinetics (CYTK) on Monday shared new analyses related to aficamten’s effects associated with standard of care combination therapy and its ...

H.C. Wainwright says that competitor data demonstrate impressive ORR in endometrial cancer, opening a potential opportunity for NetCure’s ...

HC Wainwright restated their buy rating on shares of Akebia Therapeutics (NASDAQ:AKBA – Free Report) in a research report released on Friday,Benzinga reports. The brokerage currently has a $7.50 ...

HC Wainwright reaffirmed their buy rating on shares of AC Immune (NASDAQ:ACIU – Free Report) in a report published on Friday,Benzinga reports. HC Wainwright currently has a $16.00 price target on the ...

H.C. Wainwright & Co. initiates a Buy rating on Perspective Therapeutics, citing promising cancer radiotherapy assets.

Fintel reports that on March 13, 2025, HC Wainwright & Co. initiated coverage of Perspective Therapeutics (NYSEAM:CATX) with ...

The establishment of a Strategic Bitcoin Reserve (SBR) in the U.S. is a "monumental endorsement" of the world's largest ...

Fintel reports that on February 25, 2025, HC Wainwright & Co. initiated coverage of Centrus Energy (NYSEAM:LEU) with a Buy recommendation. Analyst Price Forecast Suggests 32.46% Upside As of ...

will present at the H.C. Wainwright 3 rd Annual Cell Therapy Virtual Conference. This virtual investor event will be held on February 25, 2025. Dr. Vera will present an overview of Marker’s ...